Soleno Therapeutics Inc. buy Guggenheim
Start price
21.11.23
/
50%
€24.30
Target price
21.11.24
€36.55
Performance (%)
74.90%
Price
29.04.24
€42.42
Summary
This prediction is currently active. With a performance of 74.90% the BUY prediction by Guggenheim is a big success. This prediction currently runs until 21.11.24. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Soleno Therapeutics Inc. | 20.443% | 20.443% |
| iShares Core DAX® | -0.922% | -1.078% |
| iShares Nasdaq 100 | 0.371% | -0.556% |
| iShares Nikkei 225® | 2.224% | -2.825% |
| iShares S&P 500 | -0.026% | -0.788% |
Comments by Guggenheim for this prediction
In the thread Soleno Therapeutics Inc. diskutieren
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $40.00 price target on the stock.
Ratings data for SLNO provided by MarketBeat